Weight Loss Jabs UK means two drugs in practice, Mounjaro (tirzepatide) and Wegovy (semaglutide), and the honest summary of access is that NHS provision is real but narrow, so most people using them are paying privately. Anyone researching weight loss jabs in the UK will find the medical question is largely settled and the access question is not: eligibility, waiting lists and monthly cost are what actually determine whether someone gets treated.
Both are prescription-only medicines. Neither is available over the counter, and anything sold without a consultation is not a legitimate supply.
Weight loss jabs UK: what is actually available
Mounjaro (tirzepatide) activates both GIP and GLP-1 receptors and produces the larger average weight loss of the two. Once weekly by pen.
Wegovy (semaglutide) is a GLP-1 receptor agonist, the same molecule as Ozempic at weight-management doses. Once weekly by pen.
Saxenda (liraglutide) is the older option, injected daily, with smaller effects. It still has a place but is rarely the first choice now.
Our tirzepatide vs semaglutide comparison covers the choice between the two main ones.
The NHS route
NHS access exists and it is rationed, which is the single most important thing to understand before starting.
Wegovy is available through NHS specialist weight management services. The thresholds are broadly a BMI of 35 or above with at least one weight-related health condition, with lower thresholds applied for some ethnic groups where cardiometabolic risk begins at a lower BMI. Referral is usually via a GP into a specialist service, and waiting lists in many areas are long.
Mounjaro is being rolled out through NHS primary care in phases, beginning with the highest-need groups. In the early phase that has meant a BMI of 40 or above alongside several weight-related conditions. The eligibility bar is intended to widen over time as capacity allows.
The practical position: if you meet those criteria, start with your GP, because free treatment with proper monitoring is a better deal than anything private. If you do not, the NHS route is closed for now regardless of how much you would benefit.
The private route
Private prescribing uses lower thresholds, typically a BMI of 30 or above, or 27.5 or above with a weight-related condition such as type 2 diabetes, hypertension, sleep apnoea or dyslipidaemia.
Every legitimate UK provider now requires an identity and eligibility check before prescribing. In practice that means a video consultation, a photograph for BMI verification, or a check against your NHS record. This was tightened after regulators found people obtaining supplies with self-reported and false measurements.
The main established providers are the online arms of the large pharmacy chains and a handful of specialist telehealth services. What distinguishes a legitimate one is simple: a registered prescriber, a real consultation, a named UK pharmacy dispensing, and a refusal to prescribe if you do not qualify. A service that will sell to anyone is telling you what it is.
What it costs
Prices move, and they vary by provider and by dose, since higher maintenance doses cost more than starting doses. As a guide rather than a quote:
| Stage | Typical monthly range |
|---|---|
| Starting doses | Around £130 to £180 |
| Middle doses | Around £180 to £250 |
| Higher maintenance doses | Around £250 to £375 |
Two things follow. First, budget for the maintenance dose, not the starter price that gets advertised. The cost rises as you titrate, and people who budgeted for the first month often stop partway up.
Second, treat prices well below that range as a warning rather than a bargain. A month for under £150 at maintenance dose is not a legitimate supply chain being efficient.
The counterfeit problem
This is the part that has actually put people in hospital.
Fake pens have entered the UK market, sold through social media, unregulated websites and messaging apps. Some have contained insulin rather than tirzepatide or semaglutide, which is not a diluted version of the same thing but a different drug with a different mechanism. Insulin lowers blood glucose regardless of what your blood glucose is doing, and people who injected it believing it was a weight loss drug have experienced severe hypoglycaemia.
Regulators have issued warnings and seized counterfeit stock. The defences are unglamorous:
- Buy only from a UK pharmacy that dispenses against a prescription written by a registered prescriber
- Never buy from social media, a marketplace listing, a gym contact or a messaging app
- Be suspicious of any supply that skips a consultation
- Check the packaging against images from the manufacturer, and be alert to spelling errors, unusual batch formats or a pen that feels or works differently from your previous one
- If something looks wrong, do not use it and report it
Price is a signal here. Legitimate supply has a floor set by what the pharmacy pays.
What to expect if you start
Weight loss usually begins within the first two to four weeks, and continues over months as the dose increases. Trial data for tirzepatide at higher doses has shown average weight reductions in the region of 20% over a year or more, with semaglutide somewhat lower. Individual results vary widely, and averages include people who lost far more and far less.
Side effects are mostly gastrointestinal: nausea, constipation, diarrhoea, reflux. They cluster in the days after a dose increase and generally settle. The rare but serious one is pancreatitis, and severe persistent abdominal pain, particularly radiating to the back, needs urgent medical assessment rather than a wait-and-see approach. Our GLP-1 side effects page covers the full picture.
Two things worth knowing before starting. Muscle is lost alongside fat unless protein intake and resistance training are addressed deliberately. And weight regain after stopping is the norm rather than the exception, which makes this a long-term treatment rather than a course.
Questions worth asking a provider
What are the total monthly costs at each dose, not just the starter? Who is the prescriber and are they GMC or GPhC registered? Which pharmacy dispenses? What monitoring is included? What happens if I get side effects, and can I speak to a clinician? What is the position if there is a supply shortage mid-treatment?
A provider that answers all six clearly is running a proper service. One that answers none is running a shop.
For the drugs themselves, see our Mounjaro guide and Wegovy guide.
FAQ
Can I get weight loss jabs on the NHS?
Yes, if you meet the criteria. Wegovy is available through specialist weight management services, broadly at a BMI of 35 or above with a weight-related condition. Mounjaro is being rolled out through primary care in phases, starting with the highest-need groups. Waiting lists are often long.
What BMI do you need for a private prescription?
Usually 30 or above, or 27.5 or above with a weight-related condition such as type 2 diabetes, high blood pressure or sleep apnoea. Legitimate providers verify this rather than taking your word for it.
How much do weight loss jabs cost in the UK privately?
Roughly £130 to £180 a month at starting doses, rising to around £250 to £375 at higher maintenance doses. Budget for the maintenance figure rather than the advertised starter price.
Which is better, Mounjaro or Wegovy?
Mounjaro produces greater average weight loss in trials, acting on both GIP and GLP-1 receptors. Wegovy has a longer track record and extensive cardiovascular outcome data. The right choice depends on your health profile and is a prescriber's decision.
How do I avoid fake weight loss pens?
Buy only through a UK pharmacy dispensing against a prescription from a registered prescriber. Never buy from social media, marketplaces or messaging apps. Counterfeit pens containing insulin have caused severe hypoglycaemia and hospital admissions.
What happens when you stop?
Weight regain is the usual outcome, because the drugs work while they are in your system and stop working when they are not. Planning for long-term treatment, or for a serious maintenance strategy, is more realistic than treating it as a fixed course.
